#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER2-negative metastatic breast cancer
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2024-04-01
|
| Colección: | Journal of Bone Oncology |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2212137424000496 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|